Skip to content
StockMarketAgent
Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

TPEX/6543 stock hub

TPEX/6543 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TPEX/6543is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.3B
Taipei Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TPEX/6543
In the news

Latest news · TPEX/6543

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12P50 15.5P75 22.5
Trailing P/E23.6
P25 14.4P50 18P75 31.9
ROE6.7
P25 -16.2P50 0.3P75 9.8
ROIC4.3
P25 -11.7P50 -0.2P75 8.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TPEX/6543 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
226
Groups with data
11
Currency
TWD
Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
Taiwan
Country code
TW
Employees
743
Enterprise value
TWD 1.3B
Exchange
Taipei Exchange
Financial currency
TWD
First seen
2026-05-10
Industry
Medical Instruments & Supplies
Isin
TW0006543002
Last refreshed
2026-05-10
Market cap
TWD 1.3B
Price
TWD 22.4
Price currency
TWD
Rev Per Employee
1,048,472.41x
Sector
Healthcare
Sic
3842
Symbol
tpex/6543
Website
https://www.perfectmedical.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
4.34%
EV Earnings
24.57x
EV/EBIT
25.92x
EV/EBITDA
11.21x
EV/FCF
-15.06x
EV/Sales
1.71x
FCF yield
-7.07%
P/B ratio
1.52x
P/E ratio
23.58x
P/S ratio
1.61x
PE Ratio10 Y
25.87x
PE Ratio3 Y
21.95x
PE Ratio5 Y
20.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

25
MetricValue
EBIT Margin
6.6%
EBITDA Margin
14.6%
Gross margin
25.77%
Gross Profit
TWD 200.8M
Gross Profit Growth
-9.49%
Gross Profit Growth Q
-17.52%
Gross Profit Growth3 Y
-5.7%
Gross Profit Growth5 Y
7.76%
Net Income
TWD 54.2M
Net Income Growth
-39.13%
Net Income Growth Q
-40.86%
Net Income Growth Years
0%
Net Income Growth3 Y
-8.25%
Net Income Growth5 Y
21.6%
Pretax Margin
9.18%
Profit Margin
6.96%
Profit Per Employee
TWD 73,011
Profitable Years
7
ROA
2.61
Roa5y
3.14
ROCE
5.37
ROE
6.67
Roe5y
6.79
ROIC
4.31
Roic5y
5.33

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

22
MetricValue
Cagr1y
-23.27%
Cagr3y
14.31%
Cagr5y
0.39%
Div CAGR10
-8.76%
Div CAGR3
-18.54%
Div CAGR5
-32.74%
EPS Growth
-45.4
EPS Growth Q
-44.82
EPS Growth Years
0
EPS Growth3 Y
-14.37
EPS Growth5 Y
16.17
OCF Growth
-25.02%
OCF Growth Q
-17.95%
OCF Growth10 Y
-0.93%
OCF Growth3 Y
-5.89%
OCF Growth5 Y
-3.68%
Revenue Growth
4.68x
Revenue Growth Q
10.95x
Revenue Growth Quarters
1x
Revenue Growth Years
3x
Revenue Growth3 Y
0.8x
Revenue Growth5 Y
2.64x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
TWD 0.63
Assets
TWD 1.3B
Cash
TWD 265.6M
Current Assets
TWD 658.9M
Current Liabilities
TWD 385.7M
Debt
TWD 347.1M
Debt EBITDA
TWD 2.92
Debt Equity
TWD 0.42
Debt FCF
TWD -3.92
Equity
TWD 823.1M
Interest Coverage
7.52
Liabilities
TWD 520.9M
Long Term Assets
TWD 685.1M
Long Term Liabilities
TWD 135.2M
Net Cash
TWD -81.5M
Net Cash By Market Cap
TWD -6.51
Net Debt EBITDA
TWD 0.72
Net Debt Equity
TWD 0.1
Tangible Book Value
TWD 818M
Tangible Book Value Per Share
TWD 14.65
WACC
4.25

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.71
Inventory Turnover
2.9
Net Working Capital
TWD 220.1M
Quick ratio
1.04
Working Capital
TWD 273.2M
Working Capital Turnover
TWD 2.4

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-12.08%
Dividend Growth
-86.67%
Dividend Growth Years
0%
Dividend per share
TWD 0.2
Dividend Years
10
Dividend Yield
0.89%
Ex Div Date
2026-05-06
Last Dividend
TWD 0.2
Payout Frequency
Annual
Payout Ratio
84.46%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
-23.26%
200-day SMA
28.19
3Y total return
49.38%
50-day SMA
24.27
50-day SMA vs 200-day SMA
50under200
5Y total return
1.95%
All Time High
33.65
All Time High Change
-33.44%
All Time High Date
2020-07-03
All Time Low
14.45
All Time Low Change
55.02%
All Time Low Date
2022-10-13
ATR
0.75
Beta
0.14
Beta1y
-0.05
Beta2y
-0.12
Ch YTD
-21.4
High
22.95
High52
33
High52 Date
2025-06-23
High52ch
-32.12%
Low
22.4
Low52
20.95
Low52 Date
2026-04-21
Low52ch
6.92%
Ma50ch
-7.7%
Price vs 200-day SMA
-20.54%
RSI
42.38
RSI Monthly
38.67
RSI Weekly
28.62
Sharpe ratio
-0.73x
Sortino ratio
-0.83
Total Return
-11.19%
Tr YTD
-20.7
Tr1m
-0.87%
Tr1w
0.45%
Tr3m
-19.14%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
TWD 51.4M
Operating Income Growth
-34.37
Operating Income Growth Q
-58.34
Operating Income Growth3 Y
-16.69
Operating Income Growth5 Y
33.83
Operating margin
6.6

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
31,846,817%
Net Borrowing
160,388,000
Shares Insiders
7.36%
Shares Out
55,854,700
Shares Qo Q
7.89%
Shares Yo Y
12.08%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

62
MetricValue
Adjusted FCF
TWD -89.7M
Average Volume
72,894.25x
Bv Per Share
14.74
CAPEX
TWD -196.1M
Ch1m
-1.75
Ch1w
-0.44
Ch1y
-23.94
Ch3m
-19.86
Ch3y
31.77
Ch5y
-17.24
Ch6m
-18.84
Change
0%
Change From Open
-0.44
Close
22.4
Days Gap
0.45
Depreciation Amortization
62,359,000
Dollar Volume
50,691.2
Earnings Date
2026-05-12
EBIT
TWD 51.4M
EBITDA
TWD 113.8M
EPS
TWD 0.95
F Score
6
FCF
TWD -88.5M
FCF EV Yield
-6.64x
FCF Per Share
TWD -1.58
Financing CF
163,167,000
Fiscal Year End
December
Founded
1,989
Graham Number
17.74776
Graham Upside
-20.77
Income Tax
TWD 17.3M
Investing CF
-191,094,000
Is Primary Listing
1
Last Earnings Date
2025-11-12
Last Report Date
2025-12-31
Last Split Date
2022-08-24
Last Split Type
Forward
Lynch Fair Value
TWD 20.52
Lynch Upside
-8.41
Ma150
27.43
Ma150ch
-18.34%
Ma20
22.68
Ma20ch
-1.23%
Net CF
58,213,000
Next Earnings Date
2026-05-12
Open
22.5
P OCF Ratio
11.63
Payment Date
2026-05-29
Position In Range
0
Ppne
548,127,000
Price Date
2026-05-08
Price EBITDA
TWD 11
Ptbv Ratio
1.53
Relative Volume
0.03x
Revenue
779,015,000x
SBC By Revenue
0.16x
Share Based Comp
1,248,000
Tax By Revenue
2.22x
Tax Rate
24.17%
Tr6m
-18.11%
Volume
2,263
Z Score
3.02
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

TPEX/6543 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.9%
$0.20 annual per share
Payout ratio
+84.5%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
-32.7%
0 consecutive years of growth
Total shareholder yield
-11.2%
Next ex-dividend date: 2026-05-06
Performance

TPEX/6543 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-23.3%
S&P 500 1Y: n/a
3Y total return
+49.4%
S&P 500 3Y: n/a
5Y total return
+2.0%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns TPEX/6543?

Insider, institutional, and short-interest positioning.

Institutional ownership
n/a
Share of float held by funds and institutions
Insider ownership
+7.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+12.1%
Negative means the company is buying back shares.
Technical

TPEX/6543 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
42.4
Neutral momentum band
Price vs 200-day MA
-20.5%
50/200-day relationship not available
Beta (5Y)
0.14
Less volatile than the market
Sharpe ratio
-0.73
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TPEX/6543

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6543 stock rating?

tpex/6543 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6543 analysis?

The full report lives at /stocks/tpex/6543/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6543?

The latest report frames tpex/6543 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6543 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.